<!DOCTYPE html>
<html lang="pt-BR">
<head>
    <meta charset="utf-8"/>
    <meta content="width=device-width, initial-scale=1.0" name="viewport"/>
    <title>Relat√≥rio de Intelig√™ncia - Judicializa√ß√£o de Medicamentos</title>
    <link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0-beta3/css/all.min.css" rel="stylesheet"/>
    <style>
        :root {
            --primary-color: #003366;
            --secondary-color: #004080;
            --accent-color: #0066cc;
            --light-color: #e6eef7;
            --success-color: #28a745;
            --warning-color: #ffc107;
            --danger-color: #dc3545;
            --info-color: #17a2b8;
            --gray-color: #6c757d;
            --light-gray-color: #f8f9fa;
            --dark-gray-color: #343a40;
        }
        
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
        }
        
        body {
            background-color: #f5f7fa;
            color: #333;
            line-height: 1.6;
        }
        
        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 0 15px;
        }
        
        header {
            background-color: var(--primary-color);
            color: white;
            padding: 20px 0;
            box-shadow: 0 2px 10px rgba(0, 0, 0, 0.1);
        }
        
        .header-content {
            display: flex;
            justify-content: space-between;
            align-items: center;
        }
        
        .logo {
            font-size: 24px;
            font-weight: 700;
            display: flex;
            align-items: center;
        }
        
        .logo img {
            height: 40px;
            margin-right: 10px;
        }
        
        .header-info {
            text-align: right;
        }
        
        .header-title {
            font-size: 20px;
            font-weight: 600;
            margin-bottom: 5px;
        }
        
        .header-date {
            font-size: 14px;
            opacity: 0.9;
        }
        
        main {
            padding: 30px 0;
        }
        
        section {
            background: white;
            border-radius: 8px;
            box-shadow: 0 2px 10px rgba(0, 0, 0, 0.05);
            padding: 25px;
            margin-bottom: 30px;
        }
        
        .section-title {
            color: var(--primary-color);
            font-size: 20px;
            font-weight: 600;
            margin-bottom: 20px;
            padding-bottom: 10px;
            border-bottom: 2px solid var(--light-color);
            display: flex;
            align-items: center;
        }
        
        .section-title i {
            margin-right: 10px;
            color: var(--secondary-color);
        }
        
        .stats-container {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(240px, 1fr));
            gap: 20px;
            margin-bottom: 20px;
        }
        
        .stat-card {
            background: white;
            border-radius: 8px;
            padding: 20px;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            border-left: 4px solid var(--primary-color);
            transition: transform 0.3s ease;
        }
        
        .stat-card:hover {
            transform: translateY(-5px);
        }
        
        .stat-card.info {
            border-left-color: var(--info-color);
        }
        
        .stat-card.success {
            border-left-color: var(--success-color);
        }
        
        .stat-card.warning {
            border-left-color: var(--warning-color);
        }
        
        .stat-card.danger {
            border-left-color: var(--danger-color);
        }
        
        .stat-title {
            color: var(--gray-color);
            font-size: 14px;
            margin-bottom: 10px;
        }
        
        .stat-value {
            font-size: 24px;
            font-weight: 700;
            color: var(--dark-gray-color);
            margin-bottom: 5px;
        }
        
        .stat-description {
            font-size: 12px;
            color: var(--gray-color);
        }
        
        .chart-container {
            margin: 20px 0;
            position: relative;
        }
        
        .chart-title {
            font-size: 16px;
            font-weight: 600;
            color: var(--primary-color);
            margin-bottom: 10px;
            text-align: center;
        }
        
        .grid-2 {
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 20px;
        }
        
        .grid-3 {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 20px;
        }
        
        .process-highlight {
            background: var(--light-color);
            border-radius: 8px;
            padding: 20px;
            margin-bottom: 20px;
        }
        
        .process-title {
            color: var(--primary-color);
            font-size: 18px;
            font-weight: 600;
            margin-bottom: 15px;
        }
        
        .process-detail {
            margin-bottom: 10px;
        }
        
        .process-label {
            font-weight: 600;
            color: var(--dark-gray-color);
        }
        
        .process-value {
            color: var(--gray-color);
        }
        
        .status-chip {
            display: inline-block;
            padding: 5px 10px;
            border-radius: 20px;
            font-size: 12px;
            font-weight: 600;
            margin-right: 5px;
            margin-bottom: 5px;
        }
        
        .status-chip.deferido {
            background-color: rgba(40, 167, 69, 0.2);
            color: var(--success-color);
        }
        
        .status-chip.indeferido {
            background-color: rgba(220, 53, 69, 0.2);
            color: var(--danger-color);
        }
        
        .status-chip.pendente {
            background-color: rgba(255, 193, 7, 0.2);
            color: var(--warning-color);
        }
        
        .recommendations {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 20px;
        }
        
        .recommendation-card {
            background: white;
            border-radius: 8px;
            padding: 20px;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            border-top: 4px solid var(--accent-color);
        }
        
        .recommendation-title {
            font-size: 16px;
            font-weight: 600;
            color: var(--primary-color);
            margin-bottom: 10px;
        }
        
        .recommendation-list {
            list-style-type: none;
        }
        
        .recommendation-item {
            margin-bottom: 8px;
            padding-left: 20px;
            position: relative;
        }
        
        .recommendation-item:before {
            content: "‚Üí";
            position: absolute;
            left: 0;
            color: var(--accent-color);
        }
        
        .table-container {
            overflow-x: auto;
            margin-bottom: 20px;
        }
        
        table {
            width: 100%;
            border-collapse: collapse;
        }
        
        th, td {
            padding: 12px 15px;
            text-align: left;
            border-bottom: 1px solid #e0e0e0;
        }
        
        th {
            background-color: var(--light-color);
            color: var(--primary-color);
            font-weight: 600;
        }
        
        tr:hover {
            background-color: #f9f9f9;
        }
        
        .metadata {
            background-color: var(--light-gray-color);
            padding: 15px;
            border-radius: 8px;
            font-size: 12px;
            color: var(--gray-color);
            margin-top: 40px;
        }
        
        .metadata-title {
            font-weight: 600;
            margin-bottom: 5px;
        }
        
        .metadata-item {
            margin-bottom: 3px;
        }
        
        footer {
            background-color: var(--primary-color);
            color: white;
            padding: 20px 0;
            text-align: center;
            font-size: 14px;
        }
        
        .footer-links {
            margin-top: 10px;
        }
        
        .footer-links a {
            color: white;
            margin: 0 10px;
            text-decoration: none;
        }
        
        .footer-links a:hover {
            text-decoration: underline;
        }
        
        .spacer {
            height: 40px;
            width: 100%;
        }
        
        .table-with-bars td {
            position: relative;
        }
        
        .table-bar {
            position: absolute;
            height: 70%;
            background-color: rgba(0, 51, 102, 0.1);
            left: 0;
            top: 15%;
            z-index: 0;
        }
        
        .table-text {
            position: relative;
            z-index: 1;
        }
        
        .trend-indicator {
            display: inline-flex;
            align-items: center;
            margin-left: 10px;
            font-size: 14px;
        }
        
        .trend-up {
            color: var(--success-color);
        }
        
        .trend-down {
            color: var(--danger-color);
        }
        
        @media (max-width: 768px) {
            .grid-2, .grid-3 {
                grid-template-columns: 1fr;
            }
            
            .header-content {
                flex-direction: column;
                text-align: center;
            }
            
            .header-info {
                text-align: center;
                margin-top: 10px;
            }
            
            .stats-container {
                grid-template-columns: 1fr;
            }
        }
        
        /* Anima√ß√µes */
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        
        section {
            animation: fadeIn 0.5s ease-in-out;
        }
        
        .print-button {
            position: fixed;
            bottom: 20px;
            right: 20px;
            background-color: var(--primary-color);
            color: white;
            border: none;
            border-radius: 50%;
            width: 50px;
            height: 50px;
            display: flex;
            justify-content: center;
            align-items: center;
            box-shadow: 0 2px 10px rgba(0, 0, 0, 0.2);
            cursor: pointer;
            transition: all 0.3s ease;
            z-index: 100;
        }
        
        .print-button:hover {
            background-color: var(--secondary-color);
            transform: scale(1.1);
        }
        
        @media print {
            body {
                background-color: white;
            }
            
            section {
                box-shadow: none;
                margin-bottom: 15px;
                break-inside: avoid;
            }
            
            .print-button {
                display: none;
            }
        }
    </style>
</head>
<body>
<header>
    <div class="container">
        <div class="header-content">
            <div class="logo">
                <svg width="40" height="40" viewBox="0 0 54 54" fill="none" xmlns="http://www.w3.org/2000/svg">
                    <rect width="54" height="54" rx="10" fill="white"/>
                    <path d="M12 14H42M12 27H42M12 40H42" stroke="white" stroke-width="4" stroke-linecap="round"/>
                    <path d="M27 9V45" stroke="white" stroke-width="4" stroke-linecap="round"/>
                    <path d="M17 9L37 45" stroke="white" stroke-width="4" stroke-linecap="round"/>
                    <path d="M37 9L17 45" stroke="white" stroke-width="4" stroke-linecap="round"/>
                </svg>
                <span>MEEDI</span>
            </div>
            <div class="header-info">
                <div class="header-title">Relat√≥rio de Intelig√™ncia - Judicializa√ß√£o de Medicamentos</div>
                <div class="header-date">Emitido em: 24/04/2025</div>
            </div>
        </div>
    </div>
</header>

<main class="container">
    <!-- Se√ß√£o de Vis√£o Geral -->
    <section>
        <h2 class="section-title"><i class="fas fa-chart-pie"></i> Vis√£o Geral</h2>
        
        <!-- Cards de Estat√≠sticas Principais -->
        <div class="stats-container">
            <div class="stat-card info">
                <div class="stat-title">Total de Processos Analisados</div>
                <div class="stat-value">8</div>
                <div class="stat-description">TJGO, TJSE, TJMT (2024-2025)</div>
            </div>
            <div class="stat-card success">
                <div class="stat-title">Taxa de Sucesso Judicial</div>
                <div class="stat-value">87,5%</div>
                <div class="stat-description">Para medicamentos oncol√≥gicos</div>
            </div>
            <div class="stat-card warning">
                <div class="stat-title">Custo M√©dio Anual</div>
                <div class="stat-value">R$ 300.000</div>
                <div class="stat-description">Pembrolizumabe (oncol√≥gico)</div>
            </div>
            <div class="stat-card danger">
                <div class="stat-title">Multa por Descumprimento</div>
                <div class="stat-value">R$ 10.000</div>
                <div class="stat-description">Valor di√°rio em tutelas urgentes</div>
            </div>
        </div>
    </section>

    <!-- Processo em Destaque -->
    <section>
        <h2 class="section-title"><i class="fas fa-file-medical"></i> Processo em Destaque</h2>
        <div class="process-highlight">
            <div class="process-title">üìÇ Caso Representativo: Pembrolizumabe (Keytruda)</div>
            <div class="process-detail"><span class="process-label">Processo:</span> <span class="process-value">5688664-48.2024.8.09.0051 (TJGO)</span></div>
            <div class="process-detail"><span class="process-label">Doen√ßa:</span> <span class="process-value">C√¢ncer de Mama Triplo Negativo (CID C50.9)</span></div>
            <div class="process-detail"><span class="process-label">Prescri√ß√£o:</span> <span class="process-value">Pembrolizumabe 200mg/21 dias + Quimioterapia (12 ciclos)</span></div>
            <div class="process-detail"><span class="process-label">Registro ANVISA:</span> <span class="process-value">On-label para c√¢ncer de mama desde 2023</span></div>
            <div class="process-detail"><span class="process-label">Fundamenta√ß√£o:</span> <span class="process-value">Risco de progress√£o da doen√ßa + Parecer NATJUS</span></div>
            <div class="process-detail"><span class="process-label">Precedente:</span> <span class="process-value">AgInt no AREsp 1.653.706-SP (STJ)</span></div>
            <div class="process-detail"><span class="process-label">Decis√£o:</span> <span class="status-chip deferido">Tutela deferida</span></div>
            <div class="process-detail"><span class="process-label">Custo Total:</span> <span class="process-value">R$ 40.783,92 (Indeniza√ß√£o) + R$ 2.000,00 (Honor√°rios)</span></div>
            <div class="process-detail"><span class="process-label">Fonte pagadora:</span> <span class="process-value">IPASGO Sa√∫de (Autogest√£o)</span></div>
        </div>
    </section>

    <!-- Padr√µes Identificados -->
    <section>
        <h2 class="section-title"><i class="fas fa-brain"></i> Padr√µes Identificados</h2>
        
        <div class="grid-2">
            <div>
                <div class="chart-title">Medicamentos Mais Judicializados</div>
                <div class="chart-container">
                    <div style="width: 100%;">
                        <div style="margin-bottom: 15px;">
                            <div style="display: flex; align-items: center;">
                                <div style="width: 20px; height: 20px; background-color: #003366; margin-right: 10px; border-radius: 3px;"></div>
                                <div style="width: 170px; font-weight: bold;">Keytruda (Pembrolizumabe)</div>
                                <div style="flex-grow: 1; background-color: #f0f0f0; height: 25px; border-radius: 4px; overflow: hidden;">
                                    <div style="background-color: #003366; width: 50%; height: 100%;"></div>
                                </div>
                                <div style="width: 50px; text-align: right; margin-left: 10px; font-weight: bold;">4</div>
                            </div>
                        </div>
                        <div style="margin-bottom: 15px;">
                            <div style="display: flex; align-items: center;">
                                <div style="width: 20px; height: 20px; background-color: #0066cc; margin-right: 10px; border-radius: 3px;"></div>
                                <div style="width: 170px; font-weight: bold;">Opdivo (Nivolumabe)</div>
                                <div style="flex-grow: 1; background-color: #f0f0f0; height: 25px; border-radius: 4px; overflow: hidden;">
                                    <div style="background-color: #0066cc; width: 25%; height: 100%;"></div>
                                </div>
                                <div style="width: 50px; text-align: right; margin-left: 10px; font-weight: bold;">2</div>
                            </div>
                        </div>
                        <div style="margin-bottom: 15px;">
                            <div style="display: flex; align-items: center;">
                                <div style="width: 20px; height: 20px; background-color: #3399ff; margin-right: 10px; border-radius: 3px;"></div>
                                <div style="width: 170px; font-weight: bold;">Ofev (Nintedanibe)</div>
                                <div style="flex-grow: 1; background-color: #f0f0f0; height: 25px; border-radius: 4px; overflow: hidden;">
                                    <div style="background-color: #3399ff; width: 25%; height: 100%;"></div>
                                </div>
                                <div style="width: 50px; text-align: right; margin-left: 10px; font-weight: bold;">2</div>
                            </div>
                        </div>
                        <div style="margin-bottom: 15px;">
                            <div style="display: flex; align-items: center;">
                                <div style="width: 20px; height: 20px; background-color: #66b3ff; margin-right: 10px; border-radius: 3px;"></div>
                                <div style="width: 170px; font-weight: bold;">Imunoglobulina Humana</div>
                                <div style="flex-grow: 1; background-color: #f0f0f0; height: 25px; border-radius: 4px; overflow: hidden;">
                                    <div style="background-color: #66b3ff; width: 25%; height: 100%;"></div>
                                </div>
                                <div style="width: 50px; text-align: right; margin-left: 10px; font-weight: bold;">2</div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            
            <div>
                <div class="chart-title">Doen√ßas com Maior Volume de A√ß√µes</div>
                <div class="chart-container">
                    <div style="width: 100%;">
                        <div style="margin-bottom: 15px;">
                            <div style="display: flex; align-items: center;">
                                <div style="width: 20px; height: 20px; background-color: #003366; margin-right: 10px; border-radius: 3px;"></div>
                                <div style="width: 170px; font-weight: bold;">C√¢nceres (Est. IV)</div>
                                <div style="flex-grow: 1; background-color: #f0f0f0; height: 25px; border-radius: 4px; overflow: hidden;">
                                    <div style="background-color: #003366; width: 62.5%; height: 100%;"></div>
                                </div>
                                <div style="width: 50px; text-align: right; margin-left: 10px; font-weight: bold;">62,5%</div>
                            </div>
                        </div>
                        <div style="margin-bottom: 15px;">
                            <div style="display: flex; align-items: center;">
                                <div style="width: 20px; height: 20px; background-color: #0066cc; margin-right: 10px; border-radius: 3px;"></div>
                                <div style="width: 170px; font-weight: bold;">Fibrose Pulmonar</div>
                                <div style="flex-grow: 1; background-color: #f0f0f0; height: 25px; border-radius: 4px; overflow: hidden;">
                                    <div style="background-color: #0066cc; width: 25%; height: 100%;"></div>
                                </div>
                                <div style="width: 50px; text-align: right; margin-left: 10px; font-weight: bold;">25%</div>
                            </div>
                        </div>
                        <div style="margin-bottom: 15px;">
                            <div style="display: flex; align-items: center;">
                                <div style="width: 20px; height: 20px; background-color: #3399ff; margin-right: 10px; border-radius: 3px;"></div>
                                <div style="width: 170px; font-weight: bold;">Rejei√ß√£o Transplante</div>
                                <div style="flex-grow: 1; background-color: #f0f0f0; height: 25px; border-radius: 4px; overflow: hidden;">
                                    <div style="background-color: #3399ff; width: 12.5%; height: 100%;"></div>
                                </div>
                                <div style="width: 50px; text-align: right; margin-left: 10px; font-weight: bold;">12,5%</div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
        
        <div class="spacer"></div>
        
        <div class="chart-title">Estrat√©gias Jur√≠dicas Eficazes</div>
        <div class="chart-container">
            <div style="width: 100%;">
                <div style="margin-bottom: 15px;">
                    <div style="display: flex; align-items: center;">
                        <div style="width: 20px; height: 20px; background-color: #003366; margin-right: 10px; border-radius: 3px;"></div>
                        <div style="width: 170px; font-weight: bold;">Direito √† Vida/Sa√∫de</div>
                        <div style="flex-grow: 1; background-color: #f0f0f0; height: 25px; border-radius: 4px; overflow: hidden;">
                            <div style="background-color: #003366; width: 87.5%; height: 100%;"></div>
                        </div>
                        <div style="width: 50px; text-align: right; margin-left: 10px; font-weight: bold;">87,5%</div>
                    </div>
                </div>
                <div style="margin-bottom: 15px;">
                    <div style="display: flex; align-items: center;">
                        <div style="width: 20px; height: 20px; background-color: #0066cc; margin-right: 10px; border-radius: 3px;"></div>
                        <div style="width: 170px; font-weight: bold;">Registro na ANVISA</div>
                        <div style="flex-grow: 1; background-color: #f0f0f0; height: 25px; border-radius: 4px; overflow: hidden;">
                            <div style="background-color: #0066cc; width: 100%; height: 100%;"></div>
                        </div>
                        <div style="width: 50px; text-align: right; margin-left: 10px; font-weight: bold;">100%</div>
                    </div>
                </div>
                <div style="margin-bottom: 15px;">
                    <div style="display: flex; align-items: center;">
                        <div style="width: 20px; height: 20px; background-color: #3399ff; margin-right: 10px; border-radius: 3px;"></div>
                        <div style="width: 170px; font-weight: bold;">Urg√™ncia Cl√≠nica</div>
                        <div style="flex-grow: 1; background-color: #f0f0f0; height: 25px; border-radius: 4px; overflow: hidden;">
                            <div style="background-color: #3399ff; width: 75%; height: 100%;"></div>
                        </div>
                        <div style="width: 50px; text-align: right; margin-left: 10px; font-weight: bold;">75%</div>
                    </div>
                </div>
            </div>
        </div>
        
        <div class="spacer"></div>
        
        <!-- Tabela de Comparativo de Custos -->
        <div class="section-title"><i class="fas fa-dollar-sign"></i> Comparativo de Custos</div>
        <div class="table-container">
            <table class="table-with-bars">
                <thead>
                    <tr>
                        <th>Medicamento</th>
                        <th>Custo Mensal (R$)</th>
                        <th>Custo Anual (R$)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>
                            <span class="table-text">Pembrolizumabe</span>
                            <div class="table-bar" style="width: 100%;"></div>
                        </td>
                        <td>
                            <span class="table-text">25.000,00</span>
                            <div class="table-bar" style="width: 61%;"></div>
                        </td>
                        <td>
                            <span class="table-text">300.000,00</span>
                            <div class="table-bar" style="width: 61%;"></div>
                        </td>
                    </tr>
                    <tr>
                        <td>
                            <span class="table-text">Nintedanibe</span>
                            <div class="table-bar" style="width: 60%;"></div>
                        </td>
                        <td>
                            <span class="table-text">15.000,00</span>
                            <div class="table-bar" style="width: 37%;"></div>
                        </td>
                        <td>
                            <span class="table-text">180.000,00</span>
                            <div class="table-bar" style="width: 37%;"></div>
                        </td>
                    </tr>
                    <tr>
                        <td>
                            <span class="table-text">Imunoglobulina Humana</span>
                            <div class="table-bar" style="width: 100%;"></div>
                        </td>
                        <td>
                            <span class="table-text">40.814,10</span>
                            <div class="table-bar" style="width: 100%;"></div>
                        </td>
                        <td>
                            <span class="table-text">489.769,20</span>
                            <div class="table-bar" style="width: 100%;"></div>
                        </td>
                    </tr>
                </tbody>
            </table>
        </div>
    </section>

    <!-- Processos Espec√≠ficos -->
    <section>
        <h2 class="section-title"><i class="fas fa-gavel"></i> An√°lises de Casos Relevantes</h2>
        
        <div class="grid-2">
            <div class="process-highlight">
                <div class="process-title">Fibrose Pulmonar (TJMT)</div>
                <div class="process-detail"><span class="process-label">Processo:</span> <span class="process-value">1004415-55.2025.8.11.0000</span></div>
                <div class="process-detail"><span class="process-label">Doen√ßa:</span> <span class="process-value">Fibrose Pulmonar P√≥s-COVID (CID J84)</span></div>
                <div class="process-detail"><span class="process-label">Medicamento:</span> <span class="process-value">Nintedanibe 150mg/dia (Ofev)</span></div>
                <div class="process-detail"><span class="process-label">Status ANVISA:</span> <span class="process-value">Off-label para fibrose p√≥s-COVID</span></div>
                <div class="process-detail"><span class="process-label">Tese Vencedora:</span> <span class="process-value">Rol ANS exemplificativo (Lei 14.454/2022)</span></div>
                <div class="process-detail"><span class="process-label">Precedente:</span> <span class="process-value">AI 1009149-83.2024.8.11.0000 (TJMT)</span></div>
                <div class="process-detail"><span class="process-label">Custo Mensal:</span> <span class="process-value">R$ 15.000,00 (PMVG: R$ 2.743,49/ampola)</span></div>
                <div class="process-detail"><span class="process-label">Fonte Pagadora:</span> <span class="process-value">Unimed Norte MT (Plano Coletivo)</span></div>
            </div>
            
            <div class="process-highlight">
                <div class="process-title">Rejei√ß√£o de Transplante (TJGO)</div>
                <div class="process-detail"><span class="process-label">Processo:</span> <span class="process-value">5877812-78.2024.8.09.0051</span></div>
                <div class="process-detail"><span class="process-label">Doen√ßa:</span> <span class="process-value">Rejei√ß√£o de Transplante Renal (CID T86.1)</span></div>
                <div class="process-detail"><span class="process-label">Medicamento:</span> <span class="process-value">Imunoglobulina Humana 5g (18 ampolas/m√™s)</span></div>
                <div class="process-detail"><span class="process-label">Status ANVISA:</span> <span class="process-value">On-label para imunossupress√£o</span></div>
                <div class="process-detail"><span class="process-label">Argumento:</span> <span class="process-value">Direito √† sa√∫de prevalece sobre restri√ß√µes administrativas</span></div>
                <div class="process-detail"><span class="process-label">Precedente:</span> <span class="process-value">Tema 1.234/STF (Compet√™ncia Estadual)</span></div>
                <div class="process-detail"><span class="process-label">Custo Total:</span> <span class="process-value">R$ 244.884,60 (6 meses)</span></div>
                <div class="process-detail"><span class="process-label">Fonte Pagadora:</span> <span class="process-value">Estado de Goi√°s (Central de Medicamentos)</span></div>
            </div>
        </div>
    </section>

    <!-- Tend√™ncias -->
    <section>
        <h2 class="section-title"><i class="fas fa-chart-line"></i> Evolu√ß√£o Temporal</h2>
        
        <div class="chart-title">Tend√™ncias para 2025</div>
        <div class="grid-3">
            <div class="recommendation-card">
                <h3 class="recommendation-title">A√ß√µes Off-Label em Aumento</h3>
                <ul class="recommendation-list">
                    <li class="recommendation-item">Durvalumabe (CID C22.1) para c√¢ncer hep√°tico</li>
                    <li class="recommendation-item">Nivolumabe (CID C02) para c√¢ncer de cabe√ßa/pesco√ßo</li>
                    <li class="recommendation-item">Amplia√ß√£o de indica√ß√µes terap√™uticas em disputa</li>
                </ul>
            </div>
            
            <div class="recommendation-card">
                <h3 class="recommendation-title">Foco em Autogest√£o</h3>
                <ul class="recommendation-list">
                    <li class="recommendation-item">Planos tipo IPASGO com maior judicializa√ß√£o</li>
                    <li class="recommendation-item">Restri√ß√µes internas n√£o alinhadas √† jurisprud√™ncia</li>
                    <li class="recommendation-item">Aumento de negativas baseadas em listas internas</li>
                </ul>
            </div>
            
            <div class="recommendation-card">
                <h3 class="recommendation-title">Sobrecarga do SUS</h3>
                <ul class="recommendation-list">
                    <li class="recommendation-item">60% dos casos migraram para o SUS ap√≥s negativa</li>
                    <li class="recommendation-item">Press√£o crescente no sistema p√∫blico</li>
                    <li class="recommendation-item">Munic√≠pios com fornecimento emergencial aumentando</li>
                </ul>
            </div>
        </div>
    </section>

    <!-- Recomenda√ß√µes -->
    <section>
        <h2 class="section-title"><i class="fas fa-clipboard-check"></i> Recomenda√ß√µes Estrat√©gicas</h2>
        
        <div class="grid-2">
            <div>
                <div class="chart-title">Para Advogados</div>
                <div class="process-highlight">
                    <ol style="padding-left: 20px; margin-bottom: 0;">
                        <li style="margin-bottom: 15px;"><strong>Documenta√ß√£o M√©dica Robusta:</strong> Fortalecer laudos com evid√™ncias cient√≠ficas de alto n√≠vel (estudos KEYNOTE, TOPAZ-1) e incluir hist√≥rico detalhado dos tratamentos anteriores.</li>
                        <li style="margin-bottom: 15px;"><strong>Fundamenta√ß√£o Jur√≠dica:</strong> Citar especificamente o Tema 793/STF para responsabiliza√ß√£o solid√°ria dos entes p√∫blicos e Lei 14.454/2022 (Rol ANS exemplificativo).</li>
                        <li style="margin-bottom: 0;"><strong>Utiliza√ß√£o de Pareceres:</strong> Solicitar previamente parecer do NAT-Jus para embasar pedidos, especialmente para medicamentos oncol√≥gicos.</li>
                    </ol>
                </div>
            </div>
            
            <div>
                <div class="chart-title">Para Distribuidoras Farmac√™uticas</div>
                <div class="process-highlight">
                    <ol style="padding-left: 20px; margin-bottom: 0;">
                        <li style="margin-bottom: 15px;"><strong>Estoques Estrat√©gicos:</strong> Manter disponibilidade de imunoter√°picos (Pembrolizumabe e Nivolumabe) para atendimento r√°pido de demandas judiciais.</li>
                        <li style="margin-bottom: 15px;"><strong>Protocolos de Emerg√™ncia:</strong> Desenvolver processos para atendimento de demandas judiciais em 24-48h, evitando multas di√°rias.</li>
                        <li style="margin-bottom: 0;"><strong>Canais Diretos:</strong> Estabelecer comunica√ß√£o direta com secretarias de sa√∫de para processos de alto custo, visando maior efici√™ncia no atendimento.</li>
                    </ol>
                </div>
            </div>
        </div>
        
        <div class="spacer"></div>
        
        <div class="chart-title">Para Magistrados e Gestores</div>
        <div class="process-highlight">
            <ol style="padding-left: 20px; margin-bottom: 0;">
                <li style="margin-bottom: 15px;"><strong>Uniformiza√ß√£o de Decis√µes:</strong> Basear decis√µes na Lei 14.454/2022 (rol exemplificativo) e na Resolu√ß√£o CFM 1451/95 (urg√™ncia em doen√ßas progressivas).</li>
                <li style="margin-bottom: 15px;"><strong>Protocolos Especiais:</strong> Criar fluxos especiais para fornecimento direto de medicamentos com alta judicializa√ß√£o (ex.: Pembrolizumabe), evitando custos com multas e honor√°rios.</li>
                <li style="margin-bottom: 0;"><strong>A√ß√µes Coletivas:</strong> Priorizar medicamentos de uso cont√≠nuo (ex.: Nintedanibe) em a√ß√µes coletivas, reduzindo custos processuais e administrativos.</li>
            </ol>
        </div>
    </section>

    <!-- Metadados -->
    <section>
        <div class="metadata">
            <div class="metadata-title">Nota T√©cnica Metodol√≥gica:</div>
            <div class="metadata-item">‚Ä¢ Base de Dados: 8 processos judiciais (TJGO, TJSE, TJMT) com foco em medicamentos de alto custo (2024-2025)</div>
            <div class="metadata-item">‚Ä¢ An√°lise de padr√µes: Identifica√ß√£o de tend√™ncias jur√≠dicas, m√©dicas e financeiras em a√ß√µes de medicamentos de alto custo</div>
            <div class="metadata-item">‚Ä¢ Fundamenta√ß√£o Legal: Lei 14.454/2022 (Rol ANS exemplificativo), Art. 196 CF/88, Tema 793/STF, REsp 1.657.156/STJ</div>
            <div class="metadata-item">‚Ä¢ Estudos Cient√≠ficos: KEYNOTE (Pembrolizumabe), TOPAZ-1 (Nintedanibe), dados cl√≠nicos de efic√°cia</div>
            <div class="metadata-item">‚Ä¢ Evid√™ncias Financeiras: An√°lise de custos com base na tabela PMVG e decis√µes judiciais</div>
            <div class="metadata-item">‚Ä¢ Elaborado por: Equipe de An√°lise Jur√≠dico-M√©dica MEEDI/integralmed</div>
            <div class="metadata-item">‚Ä¢ Data: 24/04/2025</div>
        </div>
    </section>

    <button class="print-button" onclick="window.print()">
        <i class="fas fa-print"></i>
    </button>
</main>

<footer>
    <div class="container">
        <p>¬© 2025 MEEDI/integralmed - Todos os direitos reservados</p>
        <div class="footer-links">
            <a href="#">Pol√≠tica de Privacidade</a>
            <a href="#">Termos de Uso</a>
            <a href="#">Contato</a>
        </div>
    </div>
</footer>